about
Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patientsConstitutive type I interferon modulates homeostatic balance through tonic signalingInterferon alpha-2a treatment for serpiginous choroiditis.Interferons and their stimulated genes in the tumor microenvironmentA weak signal for strong responses: interferon-alpha/beta revisited.Inflammation activates the interferon signaling pathways in taste bud cells.Role of the alpha/beta interferon response in the acquisition of susceptibility to poliovirus by kidney cells in culture.Distinct roles for the NF-kappa B RelA subunit during antiviral innate immune responses.Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy.Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment.Tumor-suppressor genes: news about the interferon connection.Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alphaInterferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome.IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development.Pharmacogenomics of IFN-beta in multiple sclerosis: towards a personalized medicine approach.Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicideThe role of interferons in early pregnancy.Emerging strategies for cancer immunoprevention.Type I Interferons and Natural Killer Cell Regulation in Cancer.Antiviral agents in dermatology: current status and future prospects.An overview of cytokines and their associations with the brain. Introduction to Part VII.Tamarin alpha-interferon is active in mouse liver upon intramuscular gene delivery.Differential Effects of IFN-β on the Survival and Growth of Human Vascular Smooth Muscle and Endothelial Cells.Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis CType I interferon gene therapy protects against cytomegalovirus-induced myocarditis.Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection.Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion.
P2860
Q21144330-59BC6285-5F61-416D-AFA3-EE18145D6486Q28260631-86E9D306-AFB6-4666-AA72-A6F759F46085Q33213523-0E729612-5038-40AD-BF14-0985846484EBQ33988567-00E545F5-00F7-4042-85B4-2F161AF03989Q34238056-2D3970BF-F4F9-45D1-8B7E-A9C17E96A961Q34583489-5E0AEDAE-D775-4C80-92FF-23A742A45D03Q34647574-E23AAF59-1493-4D6E-8D84-E28BBF95D269Q34742996-DDE99C6E-4776-46DE-BFFB-B3AF23B41403Q35075276-04889CEA-9B9A-4891-951E-7C3F7B4C286FQ36135987-E536E48A-ED09-4318-9D92-C020ADDF78E0Q36381763-E01B142E-5F8A-489E-A433-5DA13726D821Q36403830-A1D2E485-73D6-4939-810E-5635E4D0B170Q36431053-5F677046-3B96-4EB9-8CF1-CB7057D36DAFQ36509839-3757FA4D-4E67-4E10-8289-33BB96CD513CQ37356528-620FEEA0-46F3-4005-900E-B9716915E417Q37375409-A03B9787-4378-487B-A2B7-CF039C654A82Q38159776-39A00EE3-104E-4824-9B91-0CEF0B720BCAQ38585850-37F03C73-0B70-4E25-9465-7078D2736C22Q39241784-EF210084-B27D-4740-BAF8-9A9A7583C250Q40433521-A912B789-6418-4D48-A5FC-C662180FFB68Q40577757-DC8439E4-1CBE-4356-8E34-A6E2A0AA3DEAQ40688854-A9E91342-52AB-44DF-B936-8616484A5B82Q41169457-DC8AF010-7C5A-4F02-A6B7-C80622B52FE7Q42415680-C91D6C52-73A5-4D2D-A8DE-9C4816711CF7Q45887549-ED0F9C10-1CE6-42CA-AE8B-968C88E982F8Q45889341-E7A5F89F-7E1C-418D-9F6E-913F890615C4Q55015760-B5FE23C3-79E8-4D42-AFC7-B8B4874735A6
P2860
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Biologic effects of interferons.
@ast
Biologic effects of interferons.
@en
type
label
Biologic effects of interferons.
@ast
Biologic effects of interferons.
@en
prefLabel
Biologic effects of interferons.
@ast
Biologic effects of interferons.
@en
P1476
Biologic effects of interferons.
@en
P2093
P2888
P304
P356
10.1111/1523-1747.EP12874776
P407
P433
P577
1990-12-01T00:00:00Z
P5875
P6179
1029521307